ATE374255T1 - Doping bei der walk-through-mutagenese - Google Patents

Doping bei der walk-through-mutagenese

Info

Publication number
ATE374255T1
ATE374255T1 AT03726328T AT03726328T ATE374255T1 AT E374255 T1 ATE374255 T1 AT E374255T1 AT 03726328 T AT03726328 T AT 03726328T AT 03726328 T AT03726328 T AT 03726328T AT E374255 T1 ATE374255 T1 AT E374255T1
Authority
AT
Austria
Prior art keywords
prototype
predetermined
synthesis
polypeptide
amino acid
Prior art date
Application number
AT03726328T
Other languages
English (en)
Inventor
Roberto Crea
Guido Cappuccilli
Original Assignee
Bioren Inc
Guido Cappuccilli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioren Inc, Guido Cappuccilli filed Critical Bioren Inc
Application granted granted Critical
Publication of ATE374255T1 publication Critical patent/ATE374255T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT03726328T 2002-04-17 2003-04-16 Doping bei der walk-through-mutagenese ATE374255T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37368602P 2002-04-17 2002-04-17

Publications (1)

Publication Number Publication Date
ATE374255T1 true ATE374255T1 (de) 2007-10-15

Family

ID=29251060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726328T ATE374255T1 (de) 2002-04-17 2003-04-16 Doping bei der walk-through-mutagenese

Country Status (12)

Country Link
US (1) US20040033569A1 (de)
EP (1) EP1495142B1 (de)
JP (1) JP4433798B2 (de)
CN (1) CN1653193A (de)
AT (1) ATE374255T1 (de)
AU (1) AU2003228568A1 (de)
CA (1) CA2482769C (de)
DE (1) DE60316547T2 (de)
ES (1) ES2295584T3 (de)
MX (1) MXPA04010222A (de)
NZ (1) NZ535928A (de)
WO (1) WO2003089671A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006023144A2 (en) 2004-07-06 2006-03-02 Bioren Inc. Look-through mutagenesis for developing altered polypeptides with enhanced properties
WO2006014498A2 (en) 2004-07-06 2006-02-09 Bioren, Inc. Universal antibody libraries
WO2006014477A1 (en) * 2004-07-06 2006-02-09 Bioren, Inc. HIGH AFFINITY ANTI-TNF-α ANTIBODIES AND METHOD
US8680019B2 (en) 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US20090176654A1 (en) * 2007-08-10 2009-07-09 Protelix, Inc. Universal fibronectin type III binding-domain libraries
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215889A (en) * 1988-11-18 1993-06-01 The Regents Of The University Of California Catalytic and reactive polypeptides and methods for their preparation and use
ES2078518T3 (es) * 1990-04-05 1995-12-16 Roberto Crea Mutagenesis por desplazamiento completo.
PT728015E (pt) * 1992-06-18 2006-07-31 Creagen Inc Antigenes polipeptidicos combinatoriais
AU1874997A (en) * 1996-02-15 1997-09-02 Pangenetics B.V. Molecules for the induction of immunological tolerance
DE60038132T2 (de) * 1999-12-27 2009-04-02 Crucell Holland B.V. Antikörper gegen Ep-Cam

Also Published As

Publication number Publication date
CA2482769C (en) 2013-10-08
ES2295584T3 (es) 2008-04-16
US20040033569A1 (en) 2004-02-19
EP1495142A4 (de) 2005-06-29
EP1495142A1 (de) 2005-01-12
DE60316547D1 (de) 2007-11-08
WO2003089671A1 (en) 2003-10-30
CA2482769A1 (en) 2003-10-30
JP4433798B2 (ja) 2010-03-17
CN1653193A (zh) 2005-08-10
JP2005523026A (ja) 2005-08-04
NZ535928A (en) 2006-09-29
EP1495142B1 (de) 2007-09-26
AU2003228568A1 (en) 2003-11-03
MXPA04010222A (es) 2005-03-07
DE60316547T2 (de) 2008-07-03

Similar Documents

Publication Publication Date Title
HUP0402271A2 (hu) Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek
DE60225586D1 (de)
ES2375058T8 (es) Axmi-010, un gen de la delta-endotoxina y métodos para su uso.
DK1178999T3 (da) L-RIBO-LNA-analoger
ATE416183T1 (de) Oligonukleotide mit alternierenden segmenten und deren verwendungen
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
ATE404679T1 (de) Neue expressionsvektoren
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
ATE373105T1 (de) Verbindungen und methoden zum nachweis von biomolekülen
TR200002989T2 (tr) Heliomisin için gen kodu ve bunun kullanılması.
HUP0303517A2 (hu) Hímfertilitást közvetítő nukleotidszekvenciák és alkalmazásuk
HUP0101991A2 (hu) Peszticid toxinok és az ezeket kódoló nukleotid szekvenciák
ATE374255T1 (de) Doping bei der walk-through-mutagenese
ES2152313T3 (es) Gen grb-3-3, sus variantes y sus utilizaciones.
WO2002048401A3 (en) Nested oligonucleotides containing hairpin for nucleic acid amplification
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
HUP0203080A2 (hu) A PRV-1 gén és felhasználása
ATE414905T1 (de) Diabetesmodell
ATE408621T1 (de) Dna moleküle
WO2005017112A3 (en) Methods of inhibiting cancer growth by binding to nuclear receptors
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
WO2005026376A3 (en) Improved methods for sequencing gc-rich and cct repeat dna templates
WO2002026964A1 (fr) Procede de construction d'une banque d'adn mutants et utilisation de celle-ci

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties